Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05719129 · ClinicalTrials.gov registry record
The Lasting Change Study
A clinical trial of Resilience, Psychological and Psychological Wellness, sponsored by Stanford University.
- Active
- Registry status
- 1,445
- Enrollment target
- 1
- Study location
NCT05719129: Active study of Resilience, Psychological and Psychological Wellness, sponsored by Stanford University.
NCT05719129 is a study of Resilience, Psychological and Psychological Wellness that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 1,445 participants, above the 586-participant average among 4 other Resilience, Psychological trials with a reported enrollment target (147% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05719129, a study of Resilience, Psychological and Psychological Wellness, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- 1,445 participants
- Enrollment target
- 1
- Study location
Study Summary
The study approach is to leverage the most cutting-edge techniques of multi-omics biology, wearable physiology, and digital real-time psychology profiling and using machine learning models to understand the mechanisms underlying the strategies and techniques that enable participants the power to initiate and maintain sustainable behavior change. Over the years, millions of people worldwide have attended immersive personal development seminars aiming to improve participants' health behaviors and wellness. Nevertheless, there's a scarcity of large-scale studies to assess their effects on behavior change and investigate their mechanism of action. A recent publication by the Science of Behavior Change Program (SOBC), launched by the National Institute of Health (NIH), recognized that: "science has not yet delivered a unified understanding of basic mechanisms of behavior change across a broad range of health-related behaviors, limiting progress in the development and translation of effective and efficacious behavioral intervention." As such, understanding the mechanisms underlying sustainable behavior change is key.
Primary Outcome
An algorithm will be used to create an index score using known biomarkers (psychosocial, physiological, and biological) related to participants' personalized mental performance. Higher index scores will indicate a better mental performance index. This outcome is assessed in the DWD group only.
Conditions Studied
Interventions
- BEHAVIORAL Date With Destiny (DWD) Seminar
Study Locations (1)
California
- Stanford university - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,445 participants |
| Start Date | 2022-11-30 |
| Est. Completion | 2025-12 |
What the registry record for NCT05719129 still lists
NCT05719129 is an observational study that tracks outcomes without assigning an intervention. Its 1,445 participants enrollment target places it among the larger protocols in the corpus, above the 586-participant average among 4 other Resilience, Psychological trials with a reported enrollment target (147% higher).
The record links to 5 conditions, with Resilience, Psychological appearing as the primary indexed condition, and to 1 intervention - of which Date With Destiny (DWD) Seminar is the first listed.
NCT05719129 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05719129 about?
NCT05719129 is a clinical study titled "The Lasting Change Study". The study approach is to leverage the most cutting-edge techniques of multi-omics biology, wearable physiology, and digital real-time psychology profiling and using machine learning models to understand the mechanisms underlying the strategies and techniques that enable participants the power to ini...
What is the current status of trial NCT05719129?
This trial is currently active not recruiting. The enrollment target is 1,445 participants. The study started on 2022-11-30. Estimated completion is 2025-12.
What conditions does trial NCT05719129 study?
This clinical trial studies the following conditions: Resilience, Psychological, Psychological Wellness, Personal and Professional Fulfilment, Wearable Devices, Multiomics.
What interventions are being tested in trial NCT05719129?
The interventions under investigation include: Date With Destiny (DWD) Seminar (BEHAVIORAL).
Who is sponsoring clinical trial NCT05719129?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05719129 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Resilience, Psychological
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- NCT05910268 · 1,450 participants · NA
Peru Decentralized HIV Care
- NCT06305312 · 1,450 participants · NA
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI